Deutsche Bank Ag\ Aptorum Group LTD Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$2.06 - $16.0 $160 - $1,248	-78 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.75 - $16.51 $8,250 - $9,906	-600 Reduced 88.5%	78 $1,000
Q3 2019 Nov 14, 2019	BUY	$15.0 - $24.49 $1,500 - $2,449	100 Added 17.3%	678 $11,000
Q2 2019 Aug 14, 2019	BUY	$13.3 - $32.55 $7,687 - $18,813	578 New	578 $14,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $8.62M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.